Replies to post #12826 on Titan Pharmaceuticals Inc (TTNP)

[rikshot]

Verrry unusual---however mm ARCA is serving at the bid & the ask----when this happens, we have "straightline chart" on occasion, 300,000 shares traded on occasion---ARCA bought up most of the shares "on the way down"----seems to have manipulated TTNP incessantly-----However---trading may have been halted & no press release or bulletin out yet (Don't you wish?) & the brass buyout god may have been appeased (Wouldn't it be nice) ----if a "DEAL" was in the workings? LOLOL

[Doctor Detroit]

Things are definitely weird, but weird is normal for Titan.

1. All indications seem to be that Braeburn has in fact gotten rid of their sales force, in which case nothing is being sold. So, the rights should be transferred back to Titan. I was struck by the following in the press release:

"There can be no assurance that this process will result in the completion of any transaction, including, but not limited to, a new licensing agreement for Probuphine with a different partner. Titan has not set a timetable for completion of the process, and it does not intend to comment further unless a specific transaction or agreement is approved by its Board of Directors."


They didn't say there can be no assurance the rights will be returned to Titan...instead, they are already talking about a transaction or agreement that will happen once the rights do return. So, it would seem things are already happening behind the scenes.

2. Everyone is waiting to see what funding comes from the federal government. Trump said absolutely nothing about opioid funding in the SOTU. Weird, because he backed $45 billion over ten years in the attempt to get rid of Obamacare. Personally, I don't think he really cares about the issue, but he will use it as a carrot to get Democrats to agree to his budget. Currently, under America Cures there is $500 million a year allocated for 2017 and 2018. The only proposal out there right now is from the Democrats: $25 billion over the next two years ($12.5 billion in each of 2018 and 2019), a lot of which would go to medicare/medicaid to fund MAT. Sad they are playing politics with peoples lives.

[Zilla]

Nobody wants to buy or sell. At least until we know what's up. I got out before because running out of money was a real possibility in 2018, so I figured more dilution. However with current events I bought back in and am willing to wait and see where this goes. I think we'll rocket if we get it back and rocket even more if we have a new partner in place after that announcement. Part of me wants to put a sell on my shares at 5, but honestly I think were worth a lot more if we don't need money for a few years. Personally, I'd be happy with a special dividend for a buyout and warrants that give us a dividend royalty with sales. That way I can't trade it anymore and I'll get a one time chunk and divi's every quarter. ;-)